Why LIMS Implementations Fail
Six patterns that play out repeatedly across genomics, molecular diagnostics, and clinical lab environments. The culprit is almost never the technology.
Read →Laboratory Technical Debt
High-throughput platforms sitting at 40% utilization. Leadership won’t approve expansion. The overhead per sample makes growth uneconomical. How technical debt accumulates—and the path out.
Read →End-to-End Workflow Strategy in Clinical Labs
How to right-size your E2E architecture for your stage of growth, find your rate-limiting steps before you buy anything, and reframe your lab as a profit center.
Read →The True Cost of Molecular Diagnostics Adoption
The seven costs labs miss before they buy — and how to model true cost of adoption.
Read →When Compromise Becomes Infrastructure
Every lab accepts compromises that fade into the operational background. Years later, they’re not decisions anymore — they’re infrastructure. How growing labs name and quantify what they stopped seeing.
Read →The Deployment Decision
The cloud vs. on-prem analysis that produced clean answers from 2017–2023 no longer holds without revisiting. A structured framework for lab leadership re-evaluating deployment strategy with current inputs.
Read →Lab Readiness Assessment
33-question interactive assessment across 10 domains. Know your gaps before you commit to a platform.
Open →LIMS Evaluation Scorecard
Score and compare LIMS vendors across deployment, integration, no-code capability, custom code exposure, workflow fit, and post-go-live support — built from real RFP experience on both sides of the table.
Open →Deployment Discovery Framework
24-question interactive framework across 8 factors. Produces a directional hypothesis — cloud, hybrid, or on-prem — for your leadership team to pressure-test. Not a verdict.
Open →Every Link in the Chain
I started my career at the end of the genomics chain and ended it owning the whole thing. HelixWrks exists to build for the problems I spent a decade watching go unsolved.
Read →